The low expression of MEF2C in the exosomes of cancer tissues will cause the reduction of CD4 + T cells and macrophage levels in the tumor microenvironment, further affecting the prognosis of CRC tumors and T, M, N, and stage, leading to accelerated cancer development and metastasis. The gene discussed is MEF2C; the disease is cancer.